Structure

Physi-Chem Properties

Molecular Weight:  572.15
Volume:  543.89
LogP:  2.751
LogD:  1.7
LogS:  -3.607
# Rotatable Bonds:  12
TPSA:  187.51
# H-Bond Aceptor:  13
# H-Bond Donor:  4
# Rings:  4
# Heavy Atoms:  13

MedChem Properties

QED Drug-Likeness Score:  0.146
Synthetic Accessibility Score:  5.204
Fsp3:  0.321
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  2
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.789
MDCK Permeability:  4.2710827983682975e-05
Pgp-inhibitor:  0.133
Pgp-substrate:  0.46
Human Intestinal Absorption (HIA):  0.899
20% Bioavailability (F20%):  0.999
30% Bioavailability (F30%):  0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.161
Plasma Protein Binding (PPB):  98.8984375%
Volume Distribution (VD):  0.385
Pgp-substrate:  1.951517105102539%

ADMET: Metabolism

CYP1A2-inhibitor:  0.401
CYP1A2-substrate:  0.685
CYP2C19-inhibitor:  0.412
CYP2C19-substrate:  0.067
CYP2C9-inhibitor:  0.885
CYP2C9-substrate:  0.662
CYP2D6-inhibitor:  0.281
CYP2D6-substrate:  0.487
CYP3A4-inhibitor:  0.769
CYP3A4-substrate:  0.296

ADMET: Excretion

Clearance (CL):  11.147
Half-life (T1/2):  0.948

ADMET: Toxicity

hERG Blockers:  0.205
Human Hepatotoxicity (H-HT):  0.344
Drug-inuced Liver Injury (DILI):  0.918
AMES Toxicity:  0.322
Rat Oral Acute Toxicity:  0.194
Maximum Recommended Daily Dose:  0.911
Skin Sensitization:  0.959
Carcinogencity:  0.291
Eye Corrosion:  0.003
Eye Irritation:  0.041
Respiratory Toxicity:  0.192

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC44730

Natural Product ID:  NPC44730
Common Name*:   Rel-(1S,2R,3R,5S,7R)-Methyl 7-Caffeoyloxymethyl-2-Hydroxy-3-Feruloyloxy-6,8-Dioxabicyclo[3.2.1]Octane-5-Carboxylate
IUPAC Name:   methyl (1S,2R,3R,5S,7R)-7-[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxymethyl]-2-hydroxy-3-[(E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylate
Synonyms:  
Standard InCHIKey:  YEMWKQFIGUCZFS-PBYGLRBLSA-N
Standard InCHI:  InChI=1S/C28H28O13/c1-36-20-12-16(4-8-18(20)30)6-10-24(33)39-21-13-28(27(35)37-2)40-22(26(41-28)25(21)34)14-38-23(32)9-5-15-3-7-17(29)19(31)11-15/h3-12,21-22,25-26,29-31,34H,13-14H2,1-2H3/b9-5+,10-6+/t21-,22-,25-,26-,28+/m1/s1
SMILES:  COc1cc(/C=C/C(=O)O[C@@H]2C[C@@]3(O[C@@H]([C@H]([C@@H]2O)O3)COC(=O)/C=C/c2ccc(c(c2)O)O)C(=O)OC)ccc1O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1077097
PubChem CID:   46184565
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000476] Cinnamic acids and derivatives
        • [CHEMONTID:0001391] Hydroxycinnamic acids and derivatives
          • [CHEMONTID:0000059] Coumaric acids and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO12088 Conyza canadensis Species Asteraceae Eukaryota n.a. n.a. n.a. PMID[20121251]
NPO12088 Conyza canadensis Species Asteraceae Eukaryota n.a. n.a. n.a. PMID[22612410]
NPO12088 Conyza canadensis Species Asteraceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO12088 Conyza canadensis Species Asteraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO12088 Conyza canadensis Species Asteraceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO12088 Conyza canadensis Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT2 Others Unspecified IC50 = 94650.0 nM PMID[472663]
NPT2 Others Unspecified Inhibition = 11.0 % PMID[472663]
NPT2 Others Unspecified Inhibition = 10.8 % PMID[472663]
NPT2 Others Unspecified IC50 = 59810.0 nM PMID[472663]
NPT2 Others Unspecified Inhibition = 48.1 % PMID[472663]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC44730 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9342 High Similarity NPC226759
0.9211 High Similarity NPC38699
0.915 High Similarity NPC471405
0.9145 High Similarity NPC327032
0.9145 High Similarity NPC191046
0.9145 High Similarity NPC194095
0.9122 High Similarity NPC98356
0.9103 High Similarity NPC289690
0.9103 High Similarity NPC288452
0.9097 High Similarity NPC44507
0.9091 High Similarity NPC40920
0.9091 High Similarity NPC472860
0.9091 High Similarity NPC223335
0.9085 High Similarity NPC10205
0.9067 High Similarity NPC478242
0.9067 High Similarity NPC476394
0.9067 High Similarity NPC98809
0.9032 High Similarity NPC469654
0.9026 High Similarity NPC473275
0.9026 High Similarity NPC163635
0.9026 High Similarity NPC470896
0.9013 High Similarity NPC36130
0.9013 High Similarity NPC93498
0.9013 High Similarity NPC163883
0.9013 High Similarity NPC134905
0.9 High Similarity NPC472969
0.898 High Similarity NPC140502
0.8974 High Similarity NPC203020
0.8974 High Similarity NPC239966
0.8968 High Similarity NPC133984
0.8954 High Similarity NPC299706
0.8954 High Similarity NPC146277
0.8954 High Similarity NPC157898
0.8954 High Similarity NPC19380
0.8954 High Similarity NPC61604
0.8954 High Similarity NPC115466
0.8954 High Similarity NPC245615
0.8954 High Similarity NPC137813
0.8947 High Similarity NPC243891
0.8947 High Similarity NPC300329
0.8933 High Similarity NPC143892
0.8933 High Similarity NPC221383
0.8933 High Similarity NPC283081
0.8933 High Similarity NPC299090
0.891 High Similarity NPC160780
0.891 High Similarity NPC289811
0.8889 High Similarity NPC267091
0.8882 High Similarity NPC221091
0.8882 High Similarity NPC259576
0.8874 High Similarity NPC192568
0.8874 High Similarity NPC471076
0.8874 High Similarity NPC98009
0.8859 High Similarity NPC160378
0.8859 High Similarity NPC110063
0.8846 High Similarity NPC1913
0.8846 High Similarity NPC286919
0.8846 High Similarity NPC475663
0.8839 High Similarity NPC145425
0.8816 High Similarity NPC111785
0.8805 High Similarity NPC223006
0.8805 High Similarity NPC272750
0.8805 High Similarity NPC227297
0.8805 High Similarity NPC173729
0.8805 High Similarity NPC134047
0.88 High Similarity NPC476382
0.88 High Similarity NPC34927
0.88 High Similarity NPC53884
0.88 High Similarity NPC262182
0.88 High Similarity NPC287615
0.88 High Similarity NPC100998
0.88 High Similarity NPC258671
0.88 High Similarity NPC216819
0.88 High Similarity NPC34587
0.88 High Similarity NPC252292
0.88 High Similarity NPC83743
0.8797 High Similarity NPC311803
0.8797 High Similarity NPC472859
0.8797 High Similarity NPC25389
0.8792 High Similarity NPC303090
0.8792 High Similarity NPC319628
0.8792 High Similarity NPC472016
0.8792 High Similarity NPC43158
0.8792 High Similarity NPC284948
0.8792 High Similarity NPC220664
0.8792 High Similarity NPC258469
0.8792 High Similarity NPC37331
0.8792 High Similarity NPC192831
0.8792 High Similarity NPC277315
0.8792 High Similarity NPC478239
0.879 High Similarity NPC179914
0.879 High Similarity NPC469384
0.8784 High Similarity NPC100675
0.8782 High Similarity NPC478055
0.8776 High Similarity NPC284409
0.8776 High Similarity NPC226005
0.8774 High Similarity NPC477299
0.8766 High Similarity NPC95498
0.8766 High Similarity NPC75695
0.8766 High Similarity NPC246566
0.8766 High Similarity NPC476434
0.8766 High Similarity NPC203664
0.8765 High Similarity NPC72249
0.8759 High Similarity NPC135127
0.8758 High Similarity NPC188393
0.8758 High Similarity NPC470934
0.8758 High Similarity NPC229882
0.8758 High Similarity NPC205054
0.8758 High Similarity NPC158635
0.8742 High Similarity NPC473867
0.8742 High Similarity NPC285108
0.8742 High Similarity NPC33298
0.8742 High Similarity NPC144557
0.8734 High Similarity NPC119125
0.8734 High Similarity NPC166277
0.8733 High Similarity NPC473090
0.8733 High Similarity NPC304956
0.8725 High Similarity NPC52664
0.8725 High Similarity NPC35702
0.8725 High Similarity NPC471027
0.8725 High Similarity NPC31751
0.8725 High Similarity NPC157816
0.8725 High Similarity NPC206095
0.8725 High Similarity NPC253722
0.8725 High Similarity NPC477335
0.8725 High Similarity NPC224389
0.8725 High Similarity NPC297517
0.8725 High Similarity NPC253481
0.8725 High Similarity NPC13818
0.8718 High Similarity NPC131532
0.8716 High Similarity NPC295492
0.8716 High Similarity NPC26241
0.8716 High Similarity NPC303683
0.8716 High Similarity NPC274891
0.8716 High Similarity NPC476819
0.8716 High Similarity NPC205751
0.8716 High Similarity NPC476820
0.8716 High Similarity NPC474875
0.8707 High Similarity NPC126206
0.8701 High Similarity NPC140151
0.8701 High Similarity NPC32079
0.869 High Similarity NPC155209
0.869 High Similarity NPC168799
0.8684 High Similarity NPC232992
0.8671 High Similarity NPC74319
0.8671 High Similarity NPC76211
0.8671 High Similarity NPC287872
0.8662 High Similarity NPC228357
0.8659 High Similarity NPC316539
0.8659 High Similarity NPC4390
0.8658 High Similarity NPC186406
0.8649 High Similarity NPC152942
0.8649 High Similarity NPC219428
0.8649 High Similarity NPC302857
0.8649 High Similarity NPC142703
0.8649 High Similarity NPC37250
0.8649 High Similarity NPC278068
0.8645 High Similarity NPC289438
0.8645 High Similarity NPC478268
0.8642 High Similarity NPC128403
0.8642 High Similarity NPC149244
0.8642 High Similarity NPC48640
0.8642 High Similarity NPC116745
0.8639 High Similarity NPC471664
0.8639 High Similarity NPC471665
0.8639 High Similarity NPC157554
0.8639 High Similarity NPC90431
0.8636 High Similarity NPC473091
0.8634 High Similarity NPC475738
0.8634 High Similarity NPC180586
0.8627 High Similarity NPC201148
0.8627 High Similarity NPC80732
0.8627 High Similarity NPC192763
0.8627 High Similarity NPC199311
0.8627 High Similarity NPC28651
0.8627 High Similarity NPC300262
0.8627 High Similarity NPC261122
0.8627 High Similarity NPC215095
0.8627 High Similarity NPC210611
0.8627 High Similarity NPC3460
0.8625 High Similarity NPC476011
0.8625 High Similarity NPC246024
0.8621 High Similarity NPC25581
0.8621 High Similarity NPC61
0.8621 High Similarity NPC18074
0.8621 High Similarity NPC5419
0.8618 High Similarity NPC287495
0.8618 High Similarity NPC199928
0.8618 High Similarity NPC9370
0.8616 High Similarity NPC289346
0.8609 High Similarity NPC232228
0.86 High Similarity NPC67467
0.8598 High Similarity NPC153755
0.8598 High Similarity NPC190003
0.8598 High Similarity NPC175107
0.8591 High Similarity NPC322021
0.8591 High Similarity NPC147379
0.859 High Similarity NPC105827
0.859 High Similarity NPC310661
0.8589 High Similarity NPC21956
0.8581 High Similarity NPC310252

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC44730 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8792 High Similarity NPD6190 Approved
0.8563 High Similarity NPD8055 Clinical (unspecified phase)
0.8553 High Similarity NPD6143 Clinical (unspecified phase)
0.8494 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8434 Intermediate Similarity NPD7685 Pre-registration
0.8415 Intermediate Similarity NPD3818 Discontinued
0.84 Intermediate Similarity NPD7266 Discontinued
0.8323 Intermediate Similarity NPD6234 Discontinued
0.8313 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8313 Intermediate Similarity NPD3882 Suspended
0.8263 Intermediate Similarity NPD6797 Phase 2
0.8239 Intermediate Similarity NPD37 Approved
0.8214 Intermediate Similarity NPD7251 Discontinued
0.8199 Intermediate Similarity NPD4965 Approved
0.8199 Intermediate Similarity NPD4966 Approved
0.8199 Intermediate Similarity NPD4967 Phase 2
0.8193 Intermediate Similarity NPD7228 Approved
0.8166 Intermediate Similarity NPD7808 Phase 3
0.8153 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.8144 Intermediate Similarity NPD7054 Approved
0.8137 Intermediate Similarity NPD3817 Phase 2
0.8121 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.8095 Intermediate Similarity NPD7074 Phase 3
0.8095 Intermediate Similarity NPD7472 Approved
0.8072 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8072 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8072 Intermediate Similarity NPD6166 Phase 2
0.8047 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD1934 Approved
0.8 Intermediate Similarity NPD7199 Phase 2
0.7987 Intermediate Similarity NPD1653 Approved
0.7927 Intermediate Similarity NPD7075 Discontinued
0.7885 Intermediate Similarity NPD4628 Phase 3
0.7853 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7853 Intermediate Similarity NPD2801 Approved
0.7829 Intermediate Similarity NPD230 Phase 1
0.7818 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7815 Intermediate Similarity NPD6233 Phase 2
0.78 Intermediate Similarity NPD3027 Phase 3
0.7765 Intermediate Similarity NPD3751 Discontinued
0.7755 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7744 Intermediate Similarity NPD1465 Phase 2
0.7744 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7719 Intermediate Similarity NPD5844 Phase 1
0.7719 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7697 Intermediate Similarity NPD5402 Approved
0.7697 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7688 Intermediate Similarity NPD6559 Discontinued
0.7688 Intermediate Similarity NPD7240 Approved
0.7684 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7683 Intermediate Similarity NPD6801 Discontinued
0.7669 Intermediate Similarity NPD4380 Phase 2
0.7667 Intermediate Similarity NPD9494 Approved
0.764 Intermediate Similarity NPD1512 Approved
0.7633 Intermediate Similarity NPD6232 Discontinued
0.7633 Intermediate Similarity NPD3787 Discontinued
0.7632 Intermediate Similarity NPD6798 Discontinued
0.7625 Intermediate Similarity NPD6799 Approved
0.7597 Intermediate Similarity NPD6355 Discontinued
0.7532 Intermediate Similarity NPD1613 Approved
0.7532 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD1511 Approved
0.7515 Intermediate Similarity NPD6385 Approved
0.7515 Intermediate Similarity NPD6386 Approved
0.7515 Intermediate Similarity NPD5494 Approved
0.75 Intermediate Similarity NPD7473 Discontinued
0.7485 Intermediate Similarity NPD5403 Approved
0.7471 Intermediate Similarity NPD8127 Discontinued
0.7468 Intermediate Similarity NPD4062 Phase 3
0.7425 Intermediate Similarity NPD8455 Phase 2
0.7419 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7383 Intermediate Similarity NPD3705 Approved
0.7375 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7374 Intermediate Similarity NPD8434 Phase 2
0.7372 Intermediate Similarity NPD1933 Approved
0.7362 Intermediate Similarity NPD5401 Approved
0.7362 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.736 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7353 Intermediate Similarity NPD919 Approved
0.7351 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7349 Intermediate Similarity NPD6599 Discontinued
0.7342 Intermediate Similarity NPD7033 Discontinued
0.7338 Intermediate Similarity NPD7095 Approved
0.7329 Intermediate Similarity NPD4110 Phase 3
0.7329 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7321 Intermediate Similarity NPD7819 Suspended
0.7308 Intermediate Similarity NPD4060 Phase 1
0.7303 Intermediate Similarity NPD8313 Approved
0.7303 Intermediate Similarity NPD8312 Approved
0.7297 Intermediate Similarity NPD1357 Approved
0.7296 Intermediate Similarity NPD2935 Discontinued
0.729 Intermediate Similarity NPD3764 Approved
0.7287 Intermediate Similarity NPD7680 Approved
0.7287 Intermediate Similarity NPD7435 Discontinued
0.7279 Intermediate Similarity NPD5536 Phase 2
0.7278 Intermediate Similarity NPD5353 Approved
0.7273 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7261 Intermediate Similarity NPD4340 Discontinued
0.7261 Intermediate Similarity NPD447 Suspended
0.7256 Intermediate Similarity NPD3688 Clinical (unspecified phase)
0.7256 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7256 Intermediate Similarity NPD3146 Approved
0.723 Intermediate Similarity NPD9545 Approved
0.7222 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD8166 Discontinued
0.7219 Intermediate Similarity NPD1608 Approved
0.7208 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7205 Intermediate Similarity NPD1549 Phase 2
0.7202 Intermediate Similarity NPD7411 Suspended
0.7191 Intermediate Similarity NPD7039 Approved
0.7191 Intermediate Similarity NPD7038 Approved
0.7186 Intermediate Similarity NPD3455 Phase 2
0.7186 Intermediate Similarity NPD7458 Discontinued
0.7184 Intermediate Similarity NPD3926 Phase 2
0.7184 Intermediate Similarity NPD5242 Approved
0.717 Intermediate Similarity NPD7097 Phase 1
0.7168 Intermediate Similarity NPD1247 Approved
0.7152 Intermediate Similarity NPD2534 Approved
0.7152 Intermediate Similarity NPD2532 Approved
0.7152 Intermediate Similarity NPD2533 Approved
0.7143 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7028 Phase 2
0.7143 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD5058 Phase 3
0.7128 Intermediate Similarity NPD6778 Approved
0.7128 Intermediate Similarity NPD6777 Approved
0.7128 Intermediate Similarity NPD6780 Approved
0.7128 Intermediate Similarity NPD6776 Approved
0.7128 Intermediate Similarity NPD6782 Approved
0.7128 Intermediate Similarity NPD6781 Approved
0.7128 Intermediate Similarity NPD6779 Approved
0.7125 Intermediate Similarity NPD1510 Phase 2
0.7118 Intermediate Similarity NPD2978 Approved
0.7118 Intermediate Similarity NPD2977 Approved
0.7107 Intermediate Similarity NPD6653 Approved
0.7105 Intermediate Similarity NPD9269 Phase 2
0.7103 Intermediate Similarity NPD228 Approved
0.7099 Intermediate Similarity NPD5958 Discontinued
0.7099 Intermediate Similarity NPD4534 Discontinued
0.7099 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD4357 Discontinued
0.7088 Intermediate Similarity NPD8150 Discontinued
0.7073 Intermediate Similarity NPD2354 Approved
0.7073 Intermediate Similarity NPD3887 Approved
0.7062 Intermediate Similarity NPD2163 Approved
0.7062 Intermediate Similarity NPD7874 Approved
0.7062 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD6674 Discontinued
0.7039 Intermediate Similarity NPD1091 Approved
0.7037 Intermediate Similarity NPD5763 Approved
0.7037 Intermediate Similarity NPD5762 Approved
0.702 Intermediate Similarity NPD17 Approved
0.7012 Intermediate Similarity NPD3750 Approved
0.7012 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD6273 Approved
0.7 Intermediate Similarity NPD2493 Approved
0.7 Intermediate Similarity NPD2494 Approved
0.6994 Remote Similarity NPD3749 Approved
0.6987 Remote Similarity NPD2861 Phase 2
0.6982 Remote Similarity NPD3226 Approved
0.6981 Remote Similarity NPD1240 Approved
0.6981 Remote Similarity NPD943 Approved
0.6981 Remote Similarity NPD3620 Phase 2
0.6981 Remote Similarity NPD3619 Clinical (unspecified phase)
0.698 Remote Similarity NPD5619 Clinical (unspecified phase)
0.6977 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6975 Remote Similarity NPD2438 Suspended
0.6975 Remote Similarity NPD2796 Approved
0.6968 Remote Similarity NPD2797 Approved
0.6962 Remote Similarity NPD3268 Approved
0.6951 Remote Similarity NPD1652 Phase 2
0.6949 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6935 Remote Similarity NPD7296 Approved
0.6933 Remote Similarity NPD6004 Phase 3
0.6933 Remote Similarity NPD6002 Phase 3
0.6933 Remote Similarity NPD6005 Phase 3
0.6933 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6933 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6932 Remote Similarity NPD7229 Phase 3
0.6928 Remote Similarity NPD1535 Discovery
0.6927 Remote Similarity NPD7698 Approved
0.6927 Remote Similarity NPD7696 Phase 3
0.6927 Remote Similarity NPD7697 Approved
0.6923 Remote Similarity NPD5647 Approved
0.6923 Remote Similarity NPD3687 Approved
0.6923 Remote Similarity NPD8151 Discontinued
0.6923 Remote Similarity NPD3686 Approved
0.6911 Remote Similarity NPD3450 Approved
0.6911 Remote Similarity NPD3452 Approved
0.6903 Remote Similarity NPD3225 Approved
0.6901 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6894 Remote Similarity NPD1607 Approved
0.6892 Remote Similarity NPD5283 Phase 1
0.6891 Remote Similarity NPD4582 Approved
0.6891 Remote Similarity NPD7870 Phase 2
0.6891 Remote Similarity NPD8320 Phase 1
0.6891 Remote Similarity NPD4583 Approved
0.6891 Remote Similarity NPD8319 Approved
0.6891 Remote Similarity NPD7871 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data